Cambridge University Press (CUP) is launching a crowdfunding campaign to publish a book under the open access model.

A $56million funding round is being announced today by Healx, the Cambridge company using artificial intelligence to find new treatments for rare diseases.

Cambridge University spin-out Sorex Sensors has launched its first product based on its breakthrough sensor technology.

Featurespace, the world-leader in fraud detection, risk prevention and Anti-Money Laundering monitoring, announced the addition of Dena Hamilton as the company's newest Fraud and Financial Crime market expert.

Cambridge-based Healx, which uses AI to repurpose drugs to fight rare diseases, has forged an important new partnership to help combat a rare childhood cancer.

A £35 million mental health research programme led by the MRC will explore what makes teenagers more or less likely to develop mental health problems and how we might intervene early.

London-based fintech Thought Machine has entered into a partnership with the Swedish financial group SEB in order to deploy its core banking system into the strategic initiative SEBx.

Featurespace, the world-leader in fraud detection and risk prevention, and Círculo de Crédito, a leading credit bureau in Latin America, have announced a partnership that will introduce the ARIC™ platform to Mexico, bringing a more effective defense against application fraud to lenders in the market.

On Friday 20th 2019 at the annual GPS World Dinner held at the Institute of Navigation GNSS+ Conference, Dr Ramsey Faragher, Founder & CEO of Focal Point Positioning was presented with the prestigious GPS World signals leadership award for their groundbreaking SuperCorrelation technology.

Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces completion of dosing and all patient visits in its Phase I clinical trial for its ultra-rapid acting insulin product candidate, AT247.

Scientists at The Institute of Cancer Research, London, are working with Healx, a biotech company specialising in artificial intelligence (AI) to discover new possible ways of treating diffuse intrinsic pontine glioma (DIPG), an essentially untreatable brain cancer in children.

Ieso Digital Health is aiming to build the next generation of mental healthcare by creating autonomous artificial intelligence-powered tools for patients.

Former maths teacher turned entrepreneur Rob Percival is today (Wednesday) launching an artificial intelligence-powered maths learning system.

Funding and trading platform is looking to grow its subsidiary in Singapore.

The Ministry of Defence (MOD) will make an investment of £1.5m across 12 winning space innovation projects from the ‘Space to Innovate’ competition held by the Defence Science and Technology Laboratory (Dstl).

Kheiron Medical Technologies, an applied science company focused on innovating cancer diagnostics through machine learning, announced a $22 million Series A round led by Atomico with participation from existing investors Connect Ventures, Greycroft, Hoxton Ventures and EXOR Seeds.

NatWest has agreed a strategic partnership with Featurespace to profile and monitor payments and account activity to prevent fraud and scams using Featurespace’s ARIC™ platform.

Bango’s results for the first half of 2019 reveal a company making significant progress, with revenue up 64 per cent to £4.32million and a ninefold increase in registrations for its app developer platform, Bango Marketplace.

FICO, a leading analytics software firm and provider of financial crime compliance solutions, today announced a partnership with Arachnys, a leader in risk investigation solutions for client onboarding, Know Your Customer (KYC), customer due diligence & enhanced due diligence (CDD/EDD), and anti-money laundering (AML).

Repositive – the Cambridge-based startup that connects researchers with the right preclinical cancer models for their research – today announced the appointment of Slaven Stekovic as Head of Strategic Growth, along with leading commercial experts (Mariana Vaschetto and Francesca Crawford) to its advisory board, to drive the company’s scale-up and global growth ambitions within the pharma and biotech market.